Inhibrx, Inc. (INBX)
NASDAQ: INBX · IEX Real-Time Price · USD
34.70
+0.21 (0.61%)
At close: May 17, 2024, 4:00 PM
34.54
-0.16 (-0.46%)
After-hours: May 17, 2024, 5:15 PM EDT

Inhibrx Revenue

Inhibrx had revenue of $1.78M in the twelve months ending March 31, 2024, with 39.30% growth year-over-year. In the year 2023, Inhibrx had annual revenue of $1.80M, a decrease of -17.88%.

Revenue (ttm)
$1.78M
Revenue Growth
+39.30%
P/S Ratio
1,020.71
Revenue / Employee
$10,366
Employees
172
Market Cap
1.82B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.80M-392.00K-17.88%
Dec 31, 20222.19M-5.04M-69.69%
Dec 31, 20217.23M-5.66M-43.89%
Dec 31, 202012.89M-323.00K-2.44%
Dec 31, 201913.21M4.62M53.71%
Dec 31, 20188.60M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Addus HomeCare 1.09B
Veracyte 375.47M
Protagonist Therapeutics 314.95M
Ginkgo Bioworks Holdings 208.70M
LeMaitre Vascular 199.89M
Ardelyx 159.11M
Fusion Pharmaceuticals 2.04M
Revenue Rankings